Skip to main content
. 2022 Jun 30;34(3):298–308. doi: 10.21147/j.issn.1000-9604.2022.03.09

Table 2. Difference in depression, anxiety, death anxiety and symptom burden between patient characteristics (N=200).

Characteristics Depression Anxiety Death anxiety Symptom burden
Median (IQR) Z Median (IQR) Z Median (IQR) Z Median (IQR) Z
CNY, Chinese Yuan; IQR, interquartile range; *, P<0.05; **, P<0.01; ***, P<0.001.
Marital status 1.11 −0.68 −0.86 −0.18
 Married 6.0 (3.0−9.0) 3.0 (1.0−6.8) 16.0 (7.0−31.8) 1.0 (0−2.0)
 Not married 4.5 (3.0−8.8) 2.0 (1.0−5.8) 13.0 (7.5−22.0) 1.0 (0−1.0)
Education 1.33 −2.43* 1.14 −0.71
 High school and below 6.0 (3.0−9.0) 2.0 (1.0−6.0) 14.5 (7.0−29.3) 1.0 (0−2.0)
 College school and above 6.0 (3.8−9.3) 4.0 (2.0−7.0) 16.5 (8.8−32.3) 2.0 (0−2.0)
Working state −0.95 −1.96* −2.33* −0.33
 Employed 6.0 (3.0−10.0) 3.0 (1.0−8.0) 18.0 (8.5−35.0) 1.0 (0−2.0)
 Unemployed or retired 6.0 (3.0−8.0) 2.0 (1.0−6.0) 12.0 (6.0−21.0) 2.0 (0−2.0)
Religion −2.04* 1.26 1.43 −0.80
 Yes 8.0 (4.0−11.0) 4.0 (2.0−7.0) 17.0 (9.0−38.0) 2.0 (0−2.0)
 No 6.0 (3.0−9.0) 3.0 (1.0−6.0) 15.0 (7.0−29.0) 1.0 (0−2.0)
Having children −0.75 −1.25 1.91 1.04
 Yes 6.0 (3.0−9.0) 3.0 (1.0−6.0) 15.0 (7.0−30.0) 1.0 (0−2.0)
 No 7.5 (1.5−16.0) 4.5 (1.3−12.3) 20.0 (10.5−51.8) 1.5 (0−4.0)
Residential location −0.21 −0.21 −0.32 −0.47
 Urban area 6.0 (3.0−9.0) 3.0 (1.0−6.0) 16.0 (7.0−31.0) 1.0 (0−2.0)
 Rural area 6.0 (3.0−10.0) 2.0 (1.0−6.5) 14.0 (7.0−26.5) 1.0 (0−2.0)
Income per month (CNY) −0.65 −1.99* 1.59 −0.05
 <7,000 6.0 (3.0−9.0) 2.0 (1.0−6.0) 15.0 (7.0−27.0) 1.0 (0−2.0)
 ≥7,000 6.0 (3.5−10.0) 5.0 (2.0−9.5) 23.0 (8.0−37.0) 2.0 (0−2.8)
Financial strain −2.16* −1.87 1.07 −2.28*
 Yes 6.0 (3.0−10.0) 3.0 (1.0−7.0) 16.0 (8.0−32.0) 2.0 (0−2.0)
 No 5.0 (2.0−7.8) 2.0 (1.0−5.0) 14.5 (3.3−29.0) 1.0 (0−1.0)
Separation and death in 5 years −0.23 −0.92 −0.50 −1.34
 Yes 6.0 (3.0−10.0) 3.0 (1.0−7.0) 16.0 (7.0−31.5) 1.0 (0−2.0)
 No 6.0 (3.0−9.0) 3.0 (1.0−6.0) 15.0 (7.0−30.8) 0 (0−2.0)
Life-threatening events in 5 years 1.18 −2.09* −3.15** −2.02*
 Yes 6.0 (5.0−13.5) 6.0 (2.0−11.0) 39.0 (16.5−54.5) 1.0 (0−5.0)
 No 6.0 (3.0−9.0) 3.0 (1.0−6.0) 15.0 (7.0−29.0) 0.5 (0−2.0)
Metastasis −0.03 −1.26 1.56 −0.13
 Organs 6.0 (3.0−9.0) 3.0 (1.0−6.0) 15.0 (7.0−29.0) 1.0 (0−2.0)
 Lymph nodes or nearby tissues 6.0 (3.0−9.5) 3.0 (1.0−10.0) 21.0 (7.5−42.5) 0 (0−2.0)
Surgery 1.24 −2.25* −0.33 −0.61
 Yes 6.0 (3.0−10.0) 3.0 (1.0−7.0) 15.5 (7.0−30.0) 1.0 (0−2.0)
 No 5.5 (1.3−8.0) 2.0 (0−5.0) 16.0 (5.5−41.8) 0 (0−2.0)
Radiotherapy −3.37*** −1.98* 1.22 −3.05**
 Yes 6.5 (4.0−11.0) 3.0 (1.0−7.0) 17.0 (8.0−30.8) 1.0 (0−2.0)
 No 4.5 (2.0−8.0) 2.0 (1.0−6.0) 14.5 (6.3−32.8) 0 (0−1.0)
Chemotherapy −0.94 −0.91 −0.40 −0.31
 Yes 6.0 (3.0−9.0) 3.0 (1.0−6.8) 15.0 (7.0−31.0) 1.0 (0−2.0)
 No 5.5 (1.3−7.8) 2.0 (0.3−5.0) 19.0 (2.5−27.5) 1.0 (0−1.0)
Endocrinotherapy −0.49 −0.14 −0.51 −0.13
 Yes 6.0 (3.0−9.0) 3.0 (1.0−6.0) 16.0 (7.0−29.5) 0.5 (0−2.0)
 No 6.0 (3.0−10.0) 3.0 (1.0−7.0) 15.0 (8.0−36.0) 1.0 (0−2.0)
Comorbidity −0.80 −2.04* −2.39* −0.60
 Yes 6.0 (2.0−9.0) 2.0 (0.3−4.0) 10.5 (5.3−22.5) 2.0 (0−1.8)
 No 6.0 (3.0−9.0) 3.0 (1.0−7.0) 17.0 (8.0−33.5) 1.0 (0−2.0)